204 related articles for article (PubMed ID: 17367207)
21. Sjögren's autoimmunity: how perturbation of recognition in endomembrane traffic may provoke pathological recognition at the cell surface.
Mircheff AK; Gierow JP; Yang T; Zhang J; Wood RL; Azzarolo AM; Warren DW; Zeng H; Guo Z; Kaslow HR; Hamm-Alvarez SF; Okamoto CT; Bachmann M
J Mol Recognit; 1998; 11(1-6):40-8. PubMed ID: 10076804
[TBL] [Abstract][Full Text] [Related]
22. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
23. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
[TBL] [Abstract][Full Text] [Related]
24. Toll-dependent selection of microbial antigens for presentation by dendritic cells.
Blander JM; Medzhitov R
Nature; 2006 Apr; 440(7085):808-12. PubMed ID: 16489357
[TBL] [Abstract][Full Text] [Related]
25. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.
Shin JS; Ebersold M; Pypaert M; Delamarre L; Hartley A; Mellman I
Nature; 2006 Nov; 444(7115):115-8. PubMed ID: 17051151
[TBL] [Abstract][Full Text] [Related]
26. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain.
Faure-André G; Vargas P; Yuseff MI; Heuzé M; Diaz J; Lankar D; Steri V; Manry J; Hugues S; Vascotto F; Boulanger J; Raposo G; Bono MR; Rosemblatt M; Piel M; Lennon-Duménil AM
Science; 2008 Dec; 322(5908):1705-10. PubMed ID: 19074353
[TBL] [Abstract][Full Text] [Related]
27. [MHC class II restricted antigen presentation].
Hirata S; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
[No Abstract] [Full Text] [Related]
28. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
29. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
[TBL] [Abstract][Full Text] [Related]
30. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
31. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
32. MHC II and the endocytic pathway: regulation by invariant chain.
Landsverk OJ; Bakke O; Gregers TF
Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
[TBL] [Abstract][Full Text] [Related]
33. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
34. Expressed Salmonella antigens within macrophages enhance the proliferation of CD4+ and CD8+ T lymphocytes by means of bystander dendritic cells.
Eguchi M; Sekiya Y; Kikuchi Y; Takaya A; Yamamoto T; Matsui H
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):411-20. PubMed ID: 17573927
[TBL] [Abstract][Full Text] [Related]
35. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
36. Localization of peptide/MHC class II complexes in macrophages following antigen processing of viable Streptococcus pyogenes.
von Delwig A; Ramachandra L; Harding CV; Robinson JH
Eur J Immunol; 2003 Sep; 33(9):2353-60. PubMed ID: 12938211
[TBL] [Abstract][Full Text] [Related]
37. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization.
Röhn TA; Boes M; Wolters D; Spindeldreher S; Müller B; Langen H; Ploegh H; Vogt AB; Kropshofer H
Nat Immunol; 2004 Sep; 5(9):909-18. PubMed ID: 15322540
[TBL] [Abstract][Full Text] [Related]
40. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]